Fifth Third Bancorp Organon & Co. Transaction History

Fifth Third Bancorp

$27.3 Billion
Q3 2024

A detailed history of Fifth Third Bancorp transactions in Organon & Co. stock. As of the latest transaction made, Fifth Third Bancorp holds 4,200 shares of OGN stock, worth $63,126. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,200

Previous 3,737 12.39%

Holding current value

$63,126

Previous $77,000 3.9%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$18.65 - $23.03 $8,634 - $10,662	463 Added 12.39%	4,200 $80,000
Q2 2024 Jul 22, 2024	BUY	$17.45 - $21.96 $1,762 - $2,217	101 Added 2.78%	3,737 $77,000
Q1 2024 Apr 23, 2024	SELL	$13.78 - $18.8 $9,177 - $12,520	-666 Reduced 15.48%	3,636 $68,000
Q4 2023 Jan 19, 2024	SELL	$10.95 - $17.32 $69,193 - $109,445	-6,319 Reduced 59.5%	4,302 $62,000
Q3 2023 Oct 31, 2023	BUY	$16.59 - $23.77 $54,846 - $78,583	3,306 Added 45.19%	10,621 $184,000
Q2 2023 Jul 25, 2023	SELL	$19.27 - $24.63 $751 - $960	-39 Reduced 0.53%	7,315 $152,000
Q1 2023 Apr 24, 2023	BUY	$21.42 - $32.08 $22,212 - $33,266	1,037 Added 16.42%	7,354 $172,000
Q4 2022 Jan 25, 2023	SELL	$23.31 - $28.61 $186 - $228	-8 Reduced 0.13%	6,317 $0
Q3 2022 Oct 25, 2022	SELL	$23.4 - $34.25 $240,739 - $352,364	-10,288 Reduced 61.93%	6,325 $148,000
Q2 2022 Aug 04, 2022	SELL	$31.66 - $38.9 $139,304 - $171,160	-4,400 Reduced 20.94%	16,613 $561,000
Q1 2022 Apr 19, 2022	SELL	$30.45 - $39.36 $130,234 - $168,342	-4,277 Reduced 16.91%	21,013 $734,000
Q4 2021 Feb 01, 2022	SELL	$28.67 - $37.13 $302,726 - $392,055	-10,559 Reduced 29.45%	25,290 $770,000
Q3 2021 Oct 15, 2021	SELL	$28.63 - $35.64 $828,494 - $1.03 Million	-28,938 Reduced 44.67%	35,849 $1.18 Million
Q2 2021 Aug 06, 2021	BUY	$28.45 - $38.0 $1.84 Million - $2.46 Million	64,787 New	64,787 $1.96 Million

Others Institutions Holding OGN

# of Institutions

790

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.82B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Organon & Co. Transaction History